Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Oncocyte Corp
(NQ:
OCX
)
3.120
+0.010 (+0.32%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Oncocyte Corp
< Previous
1
2
3
4
Next >
OCX Stock Earnings: OncoCyte Beats EPS, Misses Revenue for Q2 2024
August 08, 2024
OCX stock results show that OncoCyte beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
Via
InvestorPlace
OncoCyte’s (NASDAQ:OCX) Innovative Approach: Potential in Precision Diagnostics
June 05, 2024
Via
AB Newswire
OncoCyte's Innovative Approach: Potential in Precision Diagnostics
June 05, 2024
OncoCyte's Innovative Approach: Potential in Precision Diagnostics
Via
News Direct
OncoCyte's Innovative Approach: Potential in Precision Diagnostics
June 05, 2024
Chronic conditions such as organ transplant rejection and cancer represent significant challenges in modern healthcare, demanding precise diagnostic tools for effective management and treatment. For...
Via
TheNewswire.com
4 Analysts Assess OncoCyte: What You Need To Know
May 16, 2024
Via
Benzinga
OncoCyte's Earnings: A Preview
November 08, 2023
Via
Benzinga
Oncocyte's VitaGraftTM Kidney Identifies Transplant Rejection 10 Months Earlier
September 18, 2023
Via
ACCESSWIRE
Oncocyte to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
September 06, 2023
Via
ACCESSWIRE
OCX Stock Earnings: OncoCyte Misses EPS, Misses Revenue for Q1 2024
May 15, 2024
OCX stock results show that OncoCyte missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Via
InvestorPlace
3 Penny Stocks That Insiders Are Buying
May 07, 2024
Penny stocks are a risky business but following the insiders to your next trade can alleviate some of the risks; these are the three hottest insider buys.
Via
MarketBeat
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
April 23, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
April 15, 2024
We are starting the trading week with a dive into the biggest pre-market stock movers worth keeping tabs on for Monday morning!
Via
InvestorPlace
Oncocyte's VitaGraft Kidney Transplant Diagnostic Test Receives CMS Coverage
August 28, 2023
Via
ACCESSWIRE
Oncocyte Reports Second Quarter 2023 Financial Results
August 10, 2023
Via
ACCESSWIRE
Oncocyte to Participate in 8th Annual Needham Virtual MedTech & Diagnostics 1×1 Conference
August 08, 2023
Via
ACCESSWIRE
Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
April 15, 2024
Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic...
Via
Benzinga
Why Medical Properties Trust Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
April 15, 2024
Shares of Medical Properties Trust, Inc. (NYSE: MPW) rose sharply in today’s pre-market trading after the company announced that it sold its majority interest in Utah Hospitals.
Via
Benzinga
Oncocyte To Announce Second Quarter 2023 Financial Results
August 03, 2023
Via
ACCESSWIRE
12 Health Care Stocks Moving In Friday's After-Market Session
April 12, 2024
Via
Benzinga
OCX Stock Earnings: OncoCyte Misses EPS, Misses Revenue for Q4 2023
April 12, 2024
OCX stock results show that OncoCyte missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.
Via
InvestorPlace
Top 3 Health Care Stocks That May Collapse In Q2
April 12, 2024
As of April 12, 2024, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
April 12, 2024
Friday is here and we're starting the final day of trading this week with a breakdown of the biggest pre-market stock movers this morning!
Via
InvestorPlace
Earnings Scheduled For April 12, 2024
April 12, 2024
Companies Reporting Before The Bell • Progressive (NYSE:PGR) is projected to report quarterly earnings at $3.17 per share on revenue of $17.43 billion.
Via
Benzinga
Why NextPlat Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket
April 12, 2024
Shares of NextPlat Corp (NASDAQ: NXPL) rose sharply in today’s pre-market trading after the company reported consolidated 2023 revenues of $37.8 million, up 222% year over year
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
November 09, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
November 09, 2023
Via
Benzinga
Why AMC Entertainment Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
November 09, 2023
Gainers Intelligent Bio Solutions Inc. (NASDAQ: INBS) shares climbed 83.5% to $0.4169 after reporting first-quarter results.
Via
Benzinga
Oncocyte Regains Compliance With Nasdaq Listing Requirements
August 09, 2023
Via
ACCESSWIRE
Why Owens Corning Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
October 25, 2023
Gainers Abri SPAC I, Inc. (NASDAQ: ASPA) shares climbed 127.1% to $28.39. Abri's stockholders approved its proposed business combination with DLQ.
Via
Benzinga
Earnings Scheduled For August 10, 2023
August 10, 2023
Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterly loss at $0.39 per share on revenue of $1.60 million.
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.